FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3170143046> ?p ?o ?g. }

• W3170143046 endingPage "245" @default.
• W3170143046 startingPage "237" @default.
• W3170143046 abstract "Real-world treatment persistence to ustekinumab for Crohn's disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated.Our retrospective cohort analysis included PBS 10% sample data for ustekinumab from September 2017 to March 2020, and for other biologics from October 2007 to capture earlier line(s) of therapy. Included patients received ustekinumab for CD prescribed by a gastroenterologist. Treatment persistence overall and by prior biologic experience, mono- or combination therapy, sex and age were estimated using Kaplan-Meier methods. A Cox proportional hazards regression analysis was performed to assess the effect of age, sex and line of therapy on persistence.Data were available for 301 patients. Of these, 58.8% were female and 76.7% were aged 26-65 years. Median follow-up from first ustekinumab dispense was 16 months. Median persistence to ustekinumab had not been reached. Twelve-month persistence to ustekinumab was 82.6% (95% CI 78.1-87.5%). Patients receiving ustekinumab as their first biologic therapy had 12-month persistence of 88.0% (80.8-95.9%) compared to 80.6% (75.0-86.6%) for patients who had previously received other biologic therapies (p=0.059). The adjusted analysis showed a trend to longer persistence for patients receiving ustekinumab as their first biologic therapy compared to biologic experienced patients (HR 1.86 (95% CI 0.95-3.63), p=0.070). Males had higher persistence to ustekinumab than females (HR 0.36 (0.20-0.66), p<0.001). Receiving ustekinumab as a monotherapy or in combination with azathioprine, mercaptopurine, 5ASAs, methotrexate, or corticosteroids had no effect on persistence (p=0.22).In an Australian real-world setting, persistence to ustekinumab was demonstrated to be over 80% at 12 months. Use as monotherapy or in combination with other therapy for CD did not affect persistence. Differences in treatment persistence by gender and previous biologic use warrant further investigation as further long-term data becomes available." @default.
• W3170143046 created "2021-06-22" @default.
• W3170143046 creator A5007177310 @default.
• W3170143046 creator A5052826134 @default.
• W3170143046 creator A5060877852 @default.
• W3170143046 creator A5070413223 @default.
• W3170143046 creator A5071880760 @default.
• W3170143046 creator A5084676022 @default.
• W3170143046 date "2021-06-01" @default.
• W3170143046 modified "2023-10-18" @default.
• W3170143046 title "An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease" @default.
• W3170143046 cites W1898025493 @default.
• W3170143046 cites W1930291969 @default.
• W3170143046 cites W1984454449 @default.
• W3170143046 cites W2474412500 @default.
• W3170143046 cites W2600357914 @default.
• W3170143046 cites W2921729210 @default.
• W3170143046 cites W2947637194 @default.
• W3170143046 cites W2951164569 @default.
• W3170143046 cites W2976362764 @default.
• W3170143046 cites W2984128211 @default.
• W3170143046 cites W2996580680 @default.
• W3170143046 cites W2998000610 @default.
• W3170143046 cites W2998932415 @default.
• W3170143046 cites W2999281530 @default.
• W3170143046 cites W2999859777 @default.
• W3170143046 cites W3011039864 @default.
• W3170143046 cites W3081928722 @default.
• W3170143046 cites W4211167126 @default.
• W3170143046 doi "https://doi.org/10.2147/btt.s310076" @default.
• W3170143046 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8215905" @default.
• W3170143046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34163137" @default.
• W3170143046 hasPublicationYear "2021" @default.
• W3170143046 type Work @default.
• W3170143046 sameAs 3170143046 @default.
• W3170143046 citedByCount "7" @default.
• W3170143046 countsByYear W31701430462022 @default.
• W3170143046 countsByYear W31701430462023 @default.
• W3170143046 crossrefType "journal-article" @default.
• W3170143046 hasAuthorship W3170143046A5007177310 @default.
• W3170143046 hasAuthorship W3170143046A5052826134 @default.
• W3170143046 hasAuthorship W3170143046A5060877852 @default.
• W3170143046 hasAuthorship W3170143046A5070413223 @default.
• W3170143046 hasAuthorship W3170143046A5071880760 @default.
• W3170143046 hasAuthorship W3170143046A5084676022 @default.
• W3170143046 hasBestOaLocation W31701430461 @default.
• W3170143046 hasConcept C126322002 @default.
• W3170143046 hasConcept C127413603 @default.
• W3170143046 hasConcept C167135981 @default.
• W3170143046 hasConcept C187320778 @default.
• W3170143046 hasConcept C201903717 @default.
• W3170143046 hasConcept C2778975655 @default.
• W3170143046 hasConcept C2779134260 @default.
• W3170143046 hasConcept C2779280984 @default.
• W3170143046 hasConcept C2780132546 @default.
• W3170143046 hasConcept C2781009140 @default.
• W3170143046 hasConcept C50382708 @default.
• W3170143046 hasConcept C71924100 @default.
• W3170143046 hasConcept C72563966 @default.
• W3170143046 hasConceptScore W3170143046C126322002 @default.
• W3170143046 hasConceptScore W3170143046C127413603 @default.
• W3170143046 hasConceptScore W3170143046C167135981 @default.
• W3170143046 hasConceptScore W3170143046C187320778 @default.
• W3170143046 hasConceptScore W3170143046C201903717 @default.
• W3170143046 hasConceptScore W3170143046C2778975655 @default.
• W3170143046 hasConceptScore W3170143046C2779134260 @default.
• W3170143046 hasConceptScore W3170143046C2779280984 @default.
• W3170143046 hasConceptScore W3170143046C2780132546 @default.
• W3170143046 hasConceptScore W3170143046C2781009140 @default.
• W3170143046 hasConceptScore W3170143046C50382708 @default.
• W3170143046 hasConceptScore W3170143046C71924100 @default.
• W3170143046 hasConceptScore W3170143046C72563966 @default.
• W3170143046 hasLocation W31701430461 @default.
• W3170143046 hasLocation W31701430462 @default.
• W3170143046 hasLocation W31701430463 @default.
• W3170143046 hasOpenAccess W3170143046 @default.
• W3170143046 hasPrimaryLocation W31701430461 @default.
• W3170143046 hasRelatedWork W1971557041 @default.
• W3170143046 hasRelatedWork W1989195985 @default.
• W3170143046 hasRelatedWork W2005712411 @default.
• W3170143046 hasRelatedWork W2157077459 @default.
• W3170143046 hasRelatedWork W2314159010 @default.
• W3170143046 hasRelatedWork W2754539770 @default.
• W3170143046 hasRelatedWork W2937211356 @default.
• W3170143046 hasRelatedWork W4282970345 @default.
• W3170143046 hasRelatedWork W4312780918 @default.
• W3170143046 hasRelatedWork W4362586397 @default.
• W3170143046 hasVolume "Volume 15" @default.
• W3170143046 isParatext "false" @default.
• W3170143046 isRetracted "false" @default.
• W3170143046 magId "3170143046" @default.
• W3170143046 workType "article" @default.